tiprankstipranks
NexgenRx Inc (TSE:NXG)
TSXV:NXG
Canadian Market

NexgenRx (NXG) Stock Price & Analysis

10 Followers

NXG Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$0.18 - C$0.31
Previous CloseC$0.24
Volume240.50K
Average Volume (3M)21.28K
Market Cap
C$20.45M
Enterprise ValueC$15.39M
Total Cash (Recent Filing)C$1.94M
Total Debt (Recent Filing)C$399.28K
Price to Earnings (P/E)-51.1
Beta0.59
Aug 15, 2024
EPS EstimateN/A
Dividend Yield4.44%
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding70,921,820
10 Day Avg. Volume7,050
30 Day Avg. Volume21,283
Standard Deviation0.11
R-Squared0.01
Alpha0.00282
Financial Highlights & Ratios
Price to Book (P/B)7.05
Price to Sales (P/S)1.33
Price to Cash Flow (P/CF)5.50
P/FCF Ratio5.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

30.75%0.00%0.00%69.25%
30.75% Insiders
0.00% Other Institutional Investors
69.25% Public Companies and
Individual Investors

NXG FAQ

What was NexgenRx Inc’s price range in the past 12 months?
NexgenRx Inc lowest stock price was C$0.17 and its highest was C$0.31 in the past 12 months.
    What is NexgenRx Inc’s market cap?
    Currently, no data Available
    When is NexgenRx Inc’s upcoming earnings report date?
    NexgenRx Inc’s upcoming earnings report date is Aug 15, 2024 which is in 90 days.
      How were NexgenRx Inc’s earnings last quarter?
      Currently, no data Available
      Is NexgenRx Inc overvalued?
      According to Wall Street analysts NexgenRx Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does NexgenRx Inc pay dividends?
        NexgenRx Inc pays a Semiannually dividend of <C$0.01 which represents an annual dividend yield of 4.44%. See more information on NexgenRx Inc dividends here
          What is NexgenRx Inc’s EPS estimate?
          NexgenRx Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does NexgenRx Inc have?
          NexgenRx Inc has 70,531,200 shares outstanding.
            What happened to NexgenRx Inc’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of NexgenRx Inc?
            Currently, no hedge funds are holding shares in TSE:NXG
            ---

            NexgenRx Stock Smart Score

            N/A
            Not Ranked
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            Negative
            20 days / 200 days
            Momentum
            -16.08%
            12-Months-Change

            Fundamentals

            Return on Equity
            -4.01%
            Trailing 12-Months
            Asset Growth
            17.28%
            Trailing 12-Months

            Company Description

            NexgenRx Inc

            NexgenRx Inc administers, adjudicates and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and also provides ancillary services. Some of the products and services of the company are Dental Claims, Prescription Drug Claims and many more.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Helix BioPharma
            Tetra Bio-Pharma
            NTG Clarity Networks
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis